Different perspectives and viewpoints on the postoperative management of EGFR-mutant lung cancer

被引：0
|
作者：
Nakao, Masayuki [1 ]
Ichinose, Junji [1 ]
Matsuura, Yosuke [1 ]
Okumura, Sakae [1 ]
Mun, Mingyon [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 18期
关键词：
D O I：
10.21037/atm.2020.04.34
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)
    Liang, Wenhua
    Cai, Kaican
    Chen, Chun
    Chen, Haiquan
    Fang, Wentao
    Fu, Junke
    Fu, Xiangning
    Gao, Shugeng
    Hu, Jian
    Huang, Yunchao
    Jiang, Ganning
    Jiao, Wenjie
    Li, Shanqing
    Li, Gaofeng
    Li, Hecheng
    Li, Hui
    Li, Xiaofei
    Liang, Naixin
    Liu, Deruo
    Liu, Hongxu
    Liu, Jun
    Liu, Lunxu
    Liu, Yang
    Luo, Qingquan
    Ma, Haitao
    Mao, Weimin
    Peng, Zhongmin
    Qiao, Guibin
    Shao, Guoguang
    Tan, Lijie
    Tan, Qunyou
    Wang, Qun
    Wang, Changli
    Wu, Qingchen
    Xu, Shidong
    Xu, Songtao
    Xu, Lin
    Yang, Yue
    Yu, Fenglei
    Zhang, Baijiang
    Zhang, Lanjun
    Zhao, Bo
    Zhi, Xiuyi
    Brunelli, Alessandro
    Petersen, Rene Horsleben
    Liu, Chia-Chuan
    Ricciuti, Biagio
    Metro, Giulio
    Tuzi, Alessandro
    Suter, Matteo B.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1163 - 1173
  • [2] EGFR-Mutant Lung Cancer: New Drugs
    Sequist, Lecia
    ONCOLOGIST, 2013, 18 : S1 - S1
  • [3] New Options for EGFR-Mutant Lung Cancer
    不详
    CANCER DISCOVERY, 2015, 5 (07) : 687 - 688
  • [4] Fusion genes in EGFR-mutant lung cancer
    Kobayashi, Yoshihisa
    CANCER SCIENCE, 2021, 112 : 132 - 132
  • [5] Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
    Nagano, Tatsuya
    Tachihara, Motoko
    Hazama, Daisuke
    Nishimura, Yoshihiro
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4561 - 4563
  • [6] Management of stage IA EGFR-mutant adenocarcinoma of the lung
    Pirker, Robert
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3260 - S3262
  • [7] Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
    Zhang, Shi-Ling
    Zhang, Chan -Yuan
    Chen, Yu-Qing
    Li, Yu -Fa
    Xie, Zhi
    Zhang, Xu-Chao
    Zhou, Qing
    Zhong, Wen-Zhao
    Huang, Jie
    Sun, Hao
    Zheng, Ming-Ying
    Xiao, Fa-Man
    Yan, Hong-Hong
    Lu, Dan-Xia
    Lv, Zhi-Yi
    Wu, Yi-Long
    Chen, Hua-Jun
    Yang, Jin-Ji
    JOURNAL OF THORACIC DISEASE, 2023, 15 (09) : 4620 - 4635
  • [8] Dacomitinib: another option for EGFR-mutant lung cancer?
    Mitsudomi, Tetsuya
    LANCET ONCOLOGY, 2014, 15 (13): : 1408 - 1409
  • [9] Overcoming therapy resistance in EGFR-mutant lung cancer
    Antonio Passaro
    Pasi A. Jänne
    Tony Mok
    Solange Peters
    Nature Cancer, 2021, 2 : 377 - 391
  • [10] An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo
    Tomoshige, Koichi
    Guo, Minzhe
    Tsuchiya, Tomoshi
    Fukazawa, Takuya
    Fink-Baldauf, Iris M.
    Stuart, William D.
    Naomoto, Yoshio
    Nagayasu, Takeshi
    Maeda, Yutaka
    ONCOGENE, 2018, 37 (28) : 3894 - 3908
12345